United Therapeutics | UTHR - Ordinary Share Capital


United Therapeutics reported $42.16M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Amarin USD 20.81M 13K Dec/2025
Ardelyx USD 244.35M 1.38M Dec/2025
Baxter International USD 516.45M 2.17M Mar/2026
Bayer EUR 982.42M 0 Dec/2025
BioCryst Pharmaceuticals USD 213.06M 2.54M Dec/2025
Biogen USD 146.7M 200K Sep/2025
BioMarin Pharmaceutical USD 193.27M 969K Mar/2026
Emergent BioSolutions USD 100K 0 Jun/2023
Esperion Therapeutics USD 245.22M 39.79M Dec/2025
Gilead Sciences USD 1.24B 1000K Mar/2026
GlaxoSmithKline GBP 4.05B 20.6M Mar/2026
Halozyme Therapeutics USD 118.52M 741K Mar/2026
Insmed USD 216.52M 2.27M Mar/2026
Ionis Pharmaceuticals USD 165.9M 3.93M Mar/2026
J&J USD 2.41B 1.74M Dec/2025
Lexicon Pharmaceuticals USD 363.47M 67K Dec/2025
Moderna USD 391M 2M Sep/2025
Omeros USD 611K 17K Dec/2023
Pfizer USD 5.7B 13M Mar/2026
PTC Therapeutics USD 81.47M 1.54M Dec/2025
Regeneron Pharmaceuticals USD 105M 300K Mar/2026
Sarepta Therapeutics USD 105.57M 607K Mar/2026
Teva Pharmaceutical Industries USD 1.16B 16.72M Mar/2026
United Therapeutics USD 42.16M 1.49M Mar/2026
Vertex Pharmaceuticals USD 254.2M 200K Mar/2026